# Intuitive Surgical vs Vertex Pharmaceuticals

URL: https://funkfolio.com/compare/isrg-vs-vrtx

> Intuitive Surgical ($149.2B, P/E 52.1) and Vertex Pharmaceuticals ($135.4B, P/E 34.6) compared: size, valuation, margins, debt, cash and price change.

---

## Intuitive Surgical vs Vertex Pharmaceuticals

Intuitive Surgical (ISRG), health care, and Vertex Pharmaceuticals (VRTX), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Intuitive Surgical is worth $149.2B on the stock market and Vertex Pharmaceuticals $135.4B: Intuitive Surgical is valued at 10% more. Intuitive Surgical trades at 52.1 times earnings and Vertex Pharmaceuticals at 34.6; operating margins in their latest fiscal years were 29.3% and 34.8%. Over the past year Intuitive Surgical's share price has moved -19.9% and Vertex Pharmaceuticals's +23.5%.

### Key facts

- **Intuitive Surgical market value:** $149.2B
- **Vertex Pharmaceuticals market value:** $135.4B
- **Intuitive Surgical P/E:** 52.1
- **Vertex Pharmaceuticals P/E:** 34.6
- **Intuitive Surgical revenue:** $10.1B FY to 2025-12-31
- **Vertex Pharmaceuticals revenue:** $12B FY to 2025-12-31
- **Superinvestors holding both:** 2

Market values as of 18 Nov 2026, 05:03 UTC.

Intuitive Surgical vs Vertex Pharmaceuticals: every measure side by side

| Measure | Intuitive Surgical | Vertex Pharmaceuticals |
| --- | --- | --- |
| Sector | Health Care | Health Care |
| Country | United States | United States |
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size |  |  |
| Market cap | $149.2B higher | $135.4B lower |
| Revenue | $10.1B lower | $12B higher |
| Earnings | $2.9B lower | $4B higher |
| Employees | 17,021 higher | 6,400 lower |
| Total assets | $20.5B lower | $25.6B higher |
| Valuation |  |  |
| P/E | 52.1 higher | 34.6 lower |
| P/S | 14.8 higher | 11.3 lower |
| P/B | 9.3 higher | 6.5 lower |
| Dividend yield | 0.00% | 0.00% |
| Profitability |  |  |
| Operating margin | 29.3% lower | 34.8% higher |
| Balance sheet |  |  |
| Net assets | $17.8B lower | $18.7B higher |
| Total liabilities | $2.5B lower | $7B higher |
| Total debt | — | — |
| Cash on hand | $3.4B lower | $5.1B higher |
| Price change |  |  |
| Today | -1.65% lower | -0.67% higher |
| 1 year | -19.9% lower | +23.5% higher |

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

### Share price over one year

Each company's share price rebased to 100 on Nov 17, 2025, so the two lines start together. Price only: dividends are not included. Last: Intuitive Surgical 78.7, Vertex Pharmaceuticals 123.1.

- Intuitive Surgical (ISRG)
- Vertex Pharmaceuticals (VRTX)

Intuitive Surgical and Vertex Pharmaceuticals share prices over one year, rebased to 100: Intuitive Surgical ends at 78.7, Vertex Pharmaceuticals at 123.1.

**The chart as a table**

Month-end share prices rebased to 100

| Month end | ISRG | VRTX |
| --- | --- | --- |
| Nov 28, 2025 | 104.9 | 99.9 |
| Dec 31, 2025 | 103.6 | 104.5 |
| Jan 30, 2026 | 92.2 | 108.3 |
| Feb 27, 2026 | 92.1 | 114.5 |
| Mar 31, 2026 | 84.3 | 102.9 |
| Apr 30, 2026 | 83.7 | 98.5 |
| May 29, 2026 | 77.7 | 103.1 |
| Jun 30, 2026 | 72.7 | 114.4 |
| Jul 31, 2026 | 64.6 | 109.9 |
| Aug 31, 2026 | 68.9 | 125.5 |
| Sep 30, 2026 | 74.4 | 120.5 |
| Oct 30, 2026 | 79.0 | 128.8 |
| Nov 17, 2026 | 78.7 | 123.1 |

### Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

#### Both (2)

- [Baillie Gifford team](https://funkfolio.com/gurus/baillie-gifford) 1.0% / 0.1%
- [Jim Simons (1938–2024)](https://funkfolio.com/gurus/jim-simons) 0.3% / 0.3%

#### Intuitive Surgical only (11)

- [Frank Sands](https://funkfolio.com/gurus/frank-sands) 1.9%
- [Polen Capital team](https://funkfolio.com/gurus/polen-capital) 1.5%
- [Jensen team](https://funkfolio.com/gurus/jensen-investment) 1.3%
- [Jeremy Grantham (co-founder)](https://funkfolio.com/gurus/jeremy-grantham) 1.1%
- [Mairs & Power team](https://funkfolio.com/gurus/mairs-and-power) 0.8%
- [Brandon Haley](https://funkfolio.com/gurus/brandon-haley) 0.7%
- [Temasek](https://funkfolio.com/gurus/temasek) 0.6%
- [Philippe Laffont](https://funkfolio.com/gurus/philippe-laffont) 0.5%
- [Ken Fisher](https://funkfolio.com/gurus/ken-fisher) 0.5%
- [Cathie Wood](https://funkfolio.com/gurus/cathie-wood) 0.2%
- [Ron Baron](https://funkfolio.com/gurus/ron-baron) 0.1%

#### Vertex Pharmaceuticals only (3)

- [Tweedy, Browne team](https://funkfolio.com/gurus/tweedy-browne) 1.1%
- [Israel Englander](https://funkfolio.com/gurus/israel-englander) 0.2%
- [Ken Griffin](https://funkfolio.com/gurus/ken-griffin) 0.1%

Percentages are each holding's share of that investor's reported portfolio (under "Both": Intuitive Surgical / Vertex Pharmaceuticals). [Who owns ISRG](https://funkfolio.com/stock/ISRG/superinvestors) · [Who owns VRTX](https://funkfolio.com/stock/VRTX/superinvestors)

### More on Intuitive Surgical

- [Intuitive Surgical (ISRG) stock page](https://funkfolio.com/stock/ISRG)
- [Intuitive Surgical market cap](https://funkfolio.com/stock/ISRG/market-cap)
- [Intuitive Surgical revenue](https://funkfolio.com/stock/ISRG/revenue)
- [Intuitive Surgical P/E ratio](https://funkfolio.com/stock/ISRG/pe-ratio)
- [Intuitive Surgical operating margin](https://funkfolio.com/stock/ISRG/operating-margin)
- [Intuitive Surgical total debt](https://funkfolio.com/stock/ISRG/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### More on Vertex Pharmaceuticals

- [Vertex Pharmaceuticals (VRTX) stock page](https://funkfolio.com/stock/VRTX)
- [Vertex Pharmaceuticals market cap](https://funkfolio.com/stock/VRTX/market-cap)
- [Vertex Pharmaceuticals revenue](https://funkfolio.com/stock/VRTX/revenue)
- [Vertex Pharmaceuticals P/E ratio](https://funkfolio.com/stock/VRTX/pe-ratio)
- [Vertex Pharmaceuticals operating margin](https://funkfolio.com/stock/VRTX/operating-margin)
- [Vertex Pharmaceuticals total debt](https://funkfolio.com/stock/VRTX/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### Further comparisons

#### Intuitive Surgical against its closest peers

- [Intuitive Surgical vs Danaher](https://funkfolio.com/compare/dhr-vs-isrg)
- [Intuitive Surgical vs Pfizer](https://funkfolio.com/compare/isrg-vs-pfe)
- [Intuitive Surgical vs Novo Nordisk](https://funkfolio.com/compare/isrg-vs-nvo)

#### Vertex Pharmaceuticals against its closest peers

- [Vertex Pharmaceuticals vs Medtronic](https://funkfolio.com/compare/mdt-vs-vrtx)
- [Vertex Pharmaceuticals vs Bristol-Myers Squibb](https://funkfolio.com/compare/bmy-vs-vrtx)
- [Vertex Pharmaceuticals vs Danaher](https://funkfolio.com/compare/dhr-vs-vrtx)

### Learn

- [What market capitalization is and is not](https://funkfolio.com/learn/markets/market-capitalization)
- [P/E ratio explained](https://funkfolio.com/learn/stocks/pe-ratio)
- [Market cap vs enterprise value](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

### Questions and answers

**Which is bigger, Intuitive Surgical or Vertex Pharmaceuticals?**

By market value, Intuitive Surgical is the larger: $149.2B against $135.4B for Vertex Pharmaceuticals. By revenue in its latest fiscal year, Vertex Pharmaceuticals is the larger: $12B against $10.1B for Intuitive Surgical.

**Which has the higher P/E ratio?**

Intuitive Surgical: 52.1, against 34.6 for Vertex Pharmaceuticals. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

**Which has the higher operating margin?**

Vertex Pharmaceuticals: 34.8%, against 29.3% for Intuitive Surgical. Operating margin is operating income as a share of revenue in the latest fiscal year.

**Which has the higher dividend yield?**

Neither: both stand at 0.00%. Dividend yield is the last twelve months' dividends as a share of today's share price.

**Which superinvestors own both Intuitive Surgical and Vertex Pharmaceuticals?**

In their latest 13F filings, Baillie Gifford team and Jim Simons (1938–2024) hold both.

### Cite this page

Funkfolio, “Intuitive Surgical vs Vertex Pharmaceuticals”, data as of 18 November 2026. https://funkfolio.com/compare/isrg-vs-vrtx

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.
